These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9679734)

  • 21. Telomerase activity in human renal cell carcinoma.
    Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
    Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21.
    Clark CC; Cohen I; Eichstetter I; Cannizzaro LA; McPherson JD; Wasmuth JJ; Iozzo RV
    Genomics; 1993 Nov; 18(2):249-60. PubMed ID: 8288227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
    Sükösd F; Kuroda N; Beothe T; Kaur AP; Kovacs G
    Cancer Res; 2003 Jan; 63(2):455-7. PubMed ID: 12543802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity in renal cell carcinoma by modified telomeric repeat amplification protocol assay.
    Segawa N; Gohji K; Azuma H; Iwamoto Y; Ohnishi K; Katsuoka Y
    Int J Urol; 2003 Mar; 10(3):153-9. PubMed ID: 12622712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased actin cable organization after single chromosome introduction: association with suppression of in vitro cell growth rather than tumorigenic suppression.
    Miyamoto S; Nishida M; Miwa K; Kato H; Imamura T; Barrett JC; Shimizu M; Oshimura M; Wake N
    Mol Carcinog; 1994 Jun; 10(2):88-96. PubMed ID: 8031469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of chromosome 7 suppresses telomerase with shortening of telomeres in a human mesothelial cell line.
    Nakabayashi K; Ogino H; Michishita E; Satoh N; Ayusawa D
    Exp Cell Res; 1999 Nov; 252(2):376-82. PubMed ID: 10527627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase activity in human renal cell carcinoma.
    Sugimura K; Yoshida N; Hisatomi H; Nakatani T; Ikemoto S
    BJU Int; 1999 Apr; 83(6):693-7. PubMed ID: 10233581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.
    Lott ST; Lovell M; Naylor SL; Killary AM
    Cancer Res; 1998 Aug; 58(16):3533-7. PubMed ID: 9721855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
    Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human chromosome 5 carries a putative telomerase repressor gene.
    Kugoh H; Shigenami K; Funaki K; Barrett JC; Oshimura M
    Genes Chromosomes Cancer; 2003 Jan; 36(1):37-47. PubMed ID: 12461748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of the KIAA1199 gene is associated with cellular mortality.
    Michishita E; Garcés G; Barrett JC; Horikawa I
    Cancer Lett; 2006 Jul; 239(1):71-7. PubMed ID: 16157444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
    Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic changes and telomerase activity in human renal cell carcinoma.
    Rohde V; Sattler HP; Oehlenschläger B; Forster S; Zwergel T; Seitz G; Wullich B
    Clin Cancer Res; 1998 Jan; 4(1):197-202. PubMed ID: 9516971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.
    Yang Y; Kost-Alimova M; Ingvarsson S; Qianhui Q; Kiss H; Szeles A; Kholodnyuk I; Cuthbert A; Klein G; Imreh S
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1136-41. PubMed ID: 11158607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal cell carcinoma with clear cells, smooth muscle stroma, and negative for 3p deletion: a variant of renal angiomyoadenomatous tumour? A case report.
    Iczkowski KA; Shanks JH; Burdge AH; Cheng L
    Histopathology; 2013 Feb; 62(3):522-4. PubMed ID: 23339367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.